South Africa						                            
                            
						
 Research Article
												 Considering Prophylaxis for Cytomegalovirus Disease in Cytomegalovirus Positive Renal Transplant Recipients from Positive Donors in a Resource Limited South African Public Hospital 
												
Author(s): Paget G and Naicker SPaget G and Naicker S             
						
												
				 Giving cytomegalovirus (CMV) prophylaxis to CMV positive recipients is expensive in a resource-limited setting  like South Africa. We report a retrospective analysis of CMV disease in 47 CMV donor/recipient positive (D+/R+) adult  renal transplant patients (> 80% African Blacks) from February 2000 to November 2004 who had received four drug  induction immune suppression. We commenced routine valganciclovir prophylaxis for 3 months post renal transplant  in January 2007 and reviewed incidence of CMV disease from January 2007, in similar patients, until October 2009. Before prophylaxis, incidence of CMV disease was 32% in D+/R+ and was similar to recipient negative/donor positive  (D-/R+) patients, however graft survival analysis adjusted for CMV disease showed that D+/R+ recipients had a hazard  ratio of 2.8 (p=0.03) for poor graft outcome.  After prophylaxis, among deceased donor r.. Read More»
				  
											  
Journal of Nephrology & Therapeutics received 784 citations as per Google Scholar report